病例报告:成功治疗了一种罕见的HER2阳性晚期乳腺状细胞癌
Gui Wang1,2, Chenghui Yang3, Donglin Zeng1
1Department of General Surgery, Longquan People's Hospital, Lishui, China.
Frontiers in pharmacology
|March 8, 2024
概括
本病例报告详细介绍了一种罕见的HER2阳性乳腺状细胞癌 (SCC),该癌症已成功用HER2向药物和帕克利塔塞尔治疗. 这种组合疗法在晚期病例中证明了持续的瘤控制.
科学领域:
- 在瘤学瘤学.
- 医疗病例报告 病例报告
背景情况:
- 乳腺状细胞癌 (SCC) 是一种罕见的,激进的转移性乳腺癌亚型.
- 目前的治疗指南对于乳腺SCC缺乏共识.
- 单独使用化疗对乳腺SCC的疗效有限.
更多相关视频
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.2K
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
